Evidence map›Paper›PMID 30259088›Full record

ReviewDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2018

[Imaging and molecular genetic diagnostics for the characterization of retinal dystrophies].

J Birtel, M Gliem, F G Holz, P Herrmann

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. X-Linked Retinoschisis Masquerading Uveitis.Journal of clinical medicine · 2023
    Article
  2. The retinal phenotype in primary hyperoxaluria type 2 and 3.Pediatric nephrology (Berlin, Germany) · 2023
    Article
  3. Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  4. Fundus autofluorescence imaging.Progress in retinal and eye research · 2021
    Review
  5. Article
  6. [Subspeciality training in rare ophthalmological clinical diseases exemplified by hereditary retinal dystrophies].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Article
  7. Article
  8. Article
  9. [LHON-Treatment option despite poor initial visual acuity?]Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

J BirtelUniversitäts-Augenklinik Bonn, Universität Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. johannes.birtel@ukbonn.de.
M GliemUniversitäts-Augenklinik Bonn, Universität Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland.
F G HolzUniversitäts-Augenklinik Bonn, Universität Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland.
P HerrmannUniversitäts-Augenklinik Bonn, Universität Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland.
Universitäts-Augenklinik Bonn · DEOxford University Hospitals NHS Trust · GBUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary retinal dystrophies represent a genetically and clinically heterogeneous group of diseases. A comprehensive characterization constitutes functional and high-resolution multimodal imaging. With the advent of novel treatment options the detection of the underlying gene causing the disease is becoming more important. Technical advances in molecular genetic diagnostics enable a classification of retinal dystrophies depending on the specific genetic cause of the disease, which is important particularly against the background of newly emerging therapy approaches. Targeted next generation sequencing (NGS), in particular is now an efficient method to accomplish this and can be especially helpful to identify rare and potentially new disease-causing variants. For the interpretation of the molecular genetic results a close collaboration between ophthalmologists and geneticists is essential.

Indexed as

Retinal DystrophiesHigh-Throughput Nucleotide SequencingHumansFundus autofluorescenceGenetic disordersGenotypingNext generation sequencingPhenotyping

Identifiers

PMID30259088
OpenAlexW2892789589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.